SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Novo Nordisk A/S: Ryzodeg® (insulin degludec/insulin aspart) Passed the Review by the First Committee on Drugs of Pharmaceutical Affairs in Japan